This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Egenesis, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Wenning Qin
Introduction
Wenning Qin is an accomplished inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules. His work is characterized by a focus on innovative solutions that address complex biological challenges.
Latest Patents
Wenning Qin is credited with a patent related to "4-1Bb Binding Molecules." This patent provides isolated binding molecules that specifically bind to human 4-1BB. It includes nucleic acid molecules encoding the amino acid sequence of these binding molecules, vectors that comprise the nucleic acid molecules, and host cells that contain these vectors. Additionally, the patent outlines methods for making the binding molecules, pharmaceutical compositions that contain them, and methods for using these binding molecules or compositions.
Career Highlights
Wenning Qin is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve health outcomes through innovative therapies.
Collaborations
Wenning has collaborated with notable colleagues, including Bianca Ahrens and Sangita M Baxi. These collaborations have likely contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Wenning Qin's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in the area of binding molecules, highlight the importance of research and collaboration in advancing medical science.